Dog Degenerative Joint Disease Management

Osteoarthritis is one of the most common conditions affecting older dogs, with multimodal management combining medication, weight control, and physiotherapy offering significant welfare improvements.

Key Facts

An estimated 20% of dogs over one year of age have some degree of osteoarthritis
OA is the most common cause of chronic pain in companion animals
NSAIDs are the primary pharmacological treatment and significantly improve quality of life
Librela (bedinvetmab), a monoclonal antibody against NGF, provides monthly pain control
Weight reduction of 6-9% significantly reduces pain scores in overweight arthritic dogs
Hydrotherapy reduces joint loading while maintaining muscle mass
Omega-3 fatty acids have anti-inflammatory effects supporting joint health
Environmental modifications including ramps and orthopedic beds reduce pain burden

Welfare Considerations

Chronic arthritis pain profoundly affects dogs' daily lives - reducing willingness to exercise, play, and engage with owners. Many owners misinterpret arthritic slowing as normal aging rather than treatable pain. The development of anti-NGF monoclonal antibody therapy represents a genuine welfare advance, providing effective monthly pain control without the gastrointestinal side effects of chronic NSAID use. Combining pharmaceutical pain control with weight management and physiotherapy produces welfare outcomes that exceed what any single intervention achieves alone.

What You Can Do

Discuss pain management options with your vet if your older dog is slowing down
Request a pain assessment using validated tools like the Helsinki Chronic Pain Index
Maintain lean body weight as the single most impactful lifestyle intervention for arthritis
Ask about Librela as a monthly injection alternative to daily NSAIDs
Implement environmental modifications including ramps and non-slip flooring